Dr. Zhang earned her PhD degree in neuropharmacology from Loyola University Chicago, IL (2003); served sequentially as a research fellow at Memorial Sloan-Kettering Cancer Center, NY and research associate at Northwestern University joining VeroScience LLC in 2009 as a neuroscientist working on understanding the brain dopaminergic system in the pathogenesis and treatment of metabolic diseases such as type II diabetes. Dr. Zhang oversees research in neuropharmacology.
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
